YEWB最新业绩:诠释高增长、强展望成长型股票,强支撑处或反弹

2015年08月18日 美国中文投资网官方微信


YEWB最新业绩:诠释高增长、强展望成长型股票,强支撑处或反弹

今日,世界稀缺抗癌药物原材料提供商紫杉生物Yew Bio-Pharm Group, Inc(代码:YEWB)公布了2015年Q2及上半年业绩。从业绩数据来看,YEWB业绩非常不错,该两个时期的营收均呈激增的状态。

更为喜人的是,YEWB再获新创收来源,未来展望值得投资者关注。


以下是业绩详情:

+++++++++++++++++++++++++++++++++YEWB++++++++++++++++++++++++++++++++

Yew Bio-PharmGroup发布2015财年第二财季业绩

中国哈尔滨2015年8月18日/PRNewswire/ ——紫杉生物Yew Bio-Pharm Group, Inc(代码:YEWB),这是一家种植和出售紫杉树以及紫杉原材料的公司,主要用于中药的生产和紫杉木产品的生产。今日,公司宣布截止2015年6月30的三个月业绩和半年业绩。

2015第二财季业绩


截止6月30日的三个月

百分比


2015

2014

变动

营收:




中药原材料

$3,909,313

$1,150,855

240%

紫杉树

344,919

872,437

(60)%

木耳

405,484

-

100%

手工艺品

7,206

40,325

(82)%

总营收

$4,666,922

$2,063,527

126%

第二财季总营收同比增长126%至470万美元,而去年同期为210万美元。中药原材料的销售占到了总营收的83.8%,而紫杉树的销售则占总营收的7.4%;木耳则占总营收的8.7%;而手工艺品则占据剩下的比例。

该季度毛利为240万美元,毛利率为51%,而去年同期毛利为160万美元,毛利率为79.4%。毛利率的下滑主要是因为木耳部门毛利率的下滑,以及2015年6月发生了一笔一次性紫杉树提取物销售。

该季度运营成本增加119%至$484,475,而去年同期为$221,022。这主要是由工资及相关福利等支出的增加造成的。

该季度净利润同比增加41%至$2,005,656,而去年同期为140万美元,这主要归功于总营收的增长。摊薄后每股收益为0.03美元,与去年同期持平。

2015年上半年业绩


截止6月30日的六个月

百分比


2015

2014

变动

营收:




中药原材料

$4,866,320

$2,194,785

122%

紫杉树

1,043,671

1,836,743

(43)%

木耳

1,304,672

-

100%

手工艺品

94,714

100,016

(5)%

总营收

$7,309,377

$4,131,544

77%

2015年半年的总营收为730万美元,而去年同期为410万美元。来自中药原材料的销售占到总营收的66.6%;紫杉树的销售则占总应收的14.3%;木耳的销售则占总营收的17.8%;手工艺品则占到了剩下的1.3%。

毛利为390万美元,毛利率为52.7%,而去年同期为320万美元,毛利率为77%。毛利率的下滑主要归咎于木耳部门毛利率的下滑,以及2015年6月发生的一次性紫杉树提取物销售。

上半年公司运营成本激增146%至$956,541,而去年同期为$388,418。这主要是由工资及相关福利等支出的增加造成的。

上半年公司净利润增长6%至300万美元,而去年同期为280万美元。摊薄后每股收益为0.05美元,而去年同期为0.04美元。

截止2015年6月30日,公司拥有约$610,000的现金和320万美元的应收账款。

公司董事长兼CEO Mr. Zhiguo Wang表示:“该时期的营收同比增长126%,这主要是因为中药原材料销售和木耳部门的增长抵消了紫杉树销售的下滑。在过去半年中,木耳部门为公司的营收贡献巨大,我们预计将在2015年下半年开发更多的消费者资源和提高木耳的销售。”

他继续表示道:“我们的医药原材料销售在2015年第二季度大幅增长,主要归因于我们的关联方红豆杉药业的需求增长。红豆杉药业已经开发出一种新技术,从中医药原材料中提取红豆杉精油,并由深加工处理的红豆杉精油作为一种新产品,红豆杉香熏。红豆杉香熏的推广已经促使了中医药原料的需求增长。红豆杉香熏将于今年10月初开始销售。我们预计中医药原材料的销售将持续增长。

+++++++++++++++++++++++++++++++++YEWB++++++++++++++++++++++++++++++++

从这份长业绩中,不难发现YEWB具有三大亮点:

1、营收激增。Q2营收实现了3位数的增长;而上半年也获得了77%的高增长。其中,中药原材料的销售贡献巨大。

2、木耳部门虽然算是新成立的部门,但是其营收贡献已逐渐超过了紫杉树带来的营收。可见该部门的成立是具有前瞻性的,未来还有进一步提升的空间。

2、新需求提振展望。而YEWB透露,其相关方Yew Pharmaceutical以及研发出了紫杉蜡烛,而制作该产品需要从中药原材料中提取紫杉精油。预计一旦面市,YEWB的中药原材料需求得到大幅提升。


从YEWB的周线图来看,目前已经来到三角形整理区间的关键支撑处,而高增长、强预期的业绩表现将有望助YEWB在此企稳走高。

Disclaimer

The firm Chineseinvestors.com Inc has been compensated byYEWB 875,000 Rule 144 Restricted common stocks for a 12-month investorrelations contract. Never invest into a stock we discuss unless you can affordto lose your entire investment.

Chineseinvestors.com Inc is an independent membershipservice that specializes in providing information on stocks that in the opinionof Chineseinvestors.com has investment potential. Chineseinvestors.com Inc mayhas positions in some of the stocks discussed on the site or in email alertsand is under no obligation to disclose the size of the position or the timethat it was acquired.

Chineseinvestors.com Inc is not a registered investmentadvisor or a broker / dealer. Chineseinvestors.com Inc does not recommendwhether to buy, sell, or hold securities. Neither Chineseinvestors.com Inc noranybody affiliated with Chineseinvestors.com Inc receives any compensation fromthe companies profiled on the web site. All opinions expressed byChineseinvestors.com Inc is not a solicitation to buy, sell, or holdsecurities. Chineseinvestors.com Inc does not guarantee the accurateness andcompleteness of statements made regarding stocks discussed on the web site orin email alerts.

The past performance section provides information to thegeneral public on selected stocks Chineseinvestors.com Inc has profiled andhave performed successfully. Other stocks profiled that aren't in the pastperformance section may have performed better or worse than the stocks in thepast performance section. Past performance should not be used as an indicatorof future returns. Chineseinvestors.com Inc tries and makes the pastperformance section as accurate as possible but does not guarantee that theinformation is accurate.

Investors should not rely on the information given byChineseinvestors.com Inc to make investment decisions. Rather, investors shoulduse the information only as a starting point to do additional independentresearch so that the investor is able to make his or her own investmentdecision.

This web site and Chineseinvestors.com Inc email alertscontain "forward looking statements" within the meaning of Section27A of the Securities Act of 1933 and Section 21B of the Securities ExchangeAct of 1934. Any statements that express or involve discussions with respect topredictions, expectations, beliefs, plans, projections, objectives, goals,assumptions or future events or performance are not statements of historicalfact and may be "forward looking statements." Forward lookingstatements are based on expectations, estimates and projections at the time thestatements are made that involve a number of risks and uncertainties whichcould cause actual results or events to differ materially from those presentlyanticipated. Forward looking statements in this action may be identifiedthrough the use of words such as "expects", "will,""anticipates," "estimates," "believes," orstatements indicating certain actions "may," "could," or"might" occur.

Never invest into a stock discussed on this web site orin Chineseinvestors.com Inc email alerts unless you can afford to lose yourentire investment.

Any redistribution of information from this web site orour email alerts without the written consent of Chineseinvestors.com Inc isstrictly prohibited.

This disclaimer may change from time to time withoutnotice.

Chineseinvestors.com Inc


长按下方二维码,关注我们!





收藏 已赞